With the traditional route of accessing international markets via domestic mutual funds largely shut due to regulatory caps, distributors—specifically, mutual fund distributors and independent
Latest News
58% of Warren Buffett's $292 Billion Portfolio Is Being Wagered on 4 Unstoppable Stocks
The Oracle of Omaha is a big believer in concentrating Berkshire Hathaway’s capital in his best ideas. There isn’t a money manager on Wall
Costco Is One of the Largest Consumer Goods Companies by Market Cap. But Is It a Buy?
There are lots of fantastic consumer goods companies for investors to buy these days, many of which have long track records of beating the
The Glaring Reason Why Warren Buffett Isn't Buying His Favorite ETF Right Now
Keith Speights, The Motley Fool July 19, 2025 at 4:47 AM Key Points Past clues point to the Vanguard S&P 500 ETF being Buffett’s
US economy showing signs of tariff stress – 18 Jul 2025
Guy Le Bas from the wealth management and investment banking firm Janney Montgomery Scott says the US is going through unusual economic uncertainty as Trump’s tariffs
Japan eyes tariff talks in US next week before Aug. 1 deadline
OSAKA (Kyodo) — Japan’s top tariff negotiator Ryosei Akazawa said Saturday he intends to visit the United States possibly early next week for an
SEE IT: The pricey Federal Reserve renovation project at center of controversy
<!–> OMB Director Russ Vought unpacks concerns over the Fed’s pricey renovations on ‘Kudlow.’ The Federal Reserve on Thursday responded to the Trump administration’s inquiry
Trump’s firing of 2 Democrats on the Federal Trade Commission was unconstitutional, judge rules
By LEA SKENE A federal judge has restored a Democrat to the Federal Trade Commission, ruling that President Donald Trump illegally fired her earlier this
Peter Thiel-Backed Crypto Exchange Bullish Files for IPO
(Bloomberg) — Bullish, a digital-asset exchange operator whose backers have included billionaire Peter Thiel, filed for an initial public offering in the latest push
After Falling 68%, Where Will This Weight-Loss Drug Stock Be in 2 Years? History Shows Massive Gains Ahead.
After Falling 68%, Where Will This Weight-Loss Drug Stock Be in 2 Years? History Shows Massive Gains Ahead. Yet another biopharma name has been